Give Your Patients
a Breath of Real Relief
SONU Band is the world's first FDA-authorized, AI-personalized acoustic therapy wearable for nasal congestion and a clinically proven tool to improve CPAP adherence in your sleep patients.
Built on Trust. Proven at Scale.
81
Percent
Clinically Significant Relief Published RCT
48
Percent
More CPAP Hours / Night OSA patients, 28-day study
15
Min
Twice Daily No clinic visits ever
2×
Better Than Placebo Congestion improvement
How It Actually Works
AI-Personalized Acoustic Resonance
SONU isn't a generic vibration device. It maps each patient's sinus anatomy and delivers frequencies calibrated to their unique physiology.
Facial Scan via Smartphone
The SONU app uses the patient's front-facing camera to build a 3D digital map of their sinonasal volume a one-time setup, no clinic equipment needed.
AI Calculates Optimal Frequencies
Proprietary algorithms determine the precise resonant frequencies matched to the patient's facial geometry personalized down to the individual.
Wearable Headband Therapy
The lightweight SONU Band is placed on the head. Medical-grade bone conduction transducers deliver gentle micro-vibrations to the nasal cavity for 15 minutes.
Mucus Clears, Airways Open
Acoustic vibration promotes mucociliary clearance and reduces nasal swelling thought to work through nitric oxide activity and autonomic modulation of nasal mucosa.
Acoustic Waveform Personalized
Sound waves tuned to the patient's unique sinonasal geometry not a one-size-fits-all frequency.
Device
Lightweight headband Black or Gray
Session length
15 minutes, twice daily
App compatibility
iPhone X+ / Android 10+
Charging
USB-C, rechargeable
Age indication
12 years and older (FDA approved)
Who Benefits
The Patients Already in Your Chair
SONU addresses a condition that runs through virtually every dental sleep practice. These are patients you're already seeing — they just haven't had a non-drug option until now.
Add SONU to Your Practice
CPAP-Struggling Patients
Nasal congestion is one of the most common reasons patients abandon CPAP. A 28-day study showed SONU increased CPAP usage by 48% among OSA patients from 2.7 to 4.0 hours per night.
Allergy Sufferers Avoiding Medication
Patients with rhinitis who avoid steroids, antihistamines, or decongestants can use SONU, the first FDA-authorized non-pharmaceutical option effective as nasal steroid sprays.
Pediatric Patients (12+)
The first FDA-approved, drug-free wearable for nasal congestion in children. An ideal option for parents avoiding steroid-based treatments for adolescents with chronic allergies or mouth breathing.
Snoring & Sleep Issues
Patients presenting with snoring or mild upper airway resistance often have nasal obstruction as a primary contributor. Clearing the nasal airway can reduce snoring frequency and improve sleep quality before escalating to oral appliance therapy.
Mouth Breathers & Myofunctional
Patients referred for orofacial myofunctional therapy or with tongue posture issues often have underlying nasal obstruction. SONU supports nasal breathing as a prerequisite to successful myofunctional outcomes.
Patients Avoiding Medications
Pregnant patients, those with medication sensitivities, or patients managing complex medication regimens who need a safe, hardware-only solution. No drug interactions. No systemic effects.
Built on Published
Clinical Science
SONU is not a wellness gadget. It is a medical device with FDA De Novo authorization, peer-reviewed trial data, and an expanding body of clinical evidence specifically relevant to dental sleep medicine.
Gold-Standard RCT
A randomized trial showed 80% of participants improved nasal congestion in 2 weeks, twice the benefit of placebo.
CPAP Adherence Study
25 adults with OSA used SONU for 15 minutes nightly. Over 28 days, CPAP use rose from 2.7 to 4.0 hours — a 48% improvement.
Pediatric FDA Expansion
In June 2025, the FDA approved SONU for ages 12 and up, making it the first drug-free nasal congestion treatment for adolescents.
Approved by Experts
Endorsed by ENT specialists at Weill Cornell, UCSF, and UCF. Recognized by the American Rhinologic Society and Otolaryngic Allergy Academy.
Recognition
TIME Magazine — Best Inventions of 2025, Health & Wellness
For DentuluPro Providers
Why This Belongs in Your Sleep Practice
SONU fits naturally into the airway and sleep care workflow that Dentulu providers are already building.
Add SONU to Your PracticeComplement Your MAD Therapy
Nasal obstruction is a root cause of CPAP failure and a complicating factor in MAD therapy. Addressing it pharmacologically-free before or alongside oral appliance therapy improves overall outcomes.
A Tool, Not a Referral Out
Instead of sending congested patients to an ENT with no guaranteed return path, you can address the nasal component directly keeping the patient in your care continuum.
Zero Chairside Setup Required
No fitting or impressions needed. Patients set up the device at home via the app. Your role is to recommend and monitor, fully supported by Dentulu’s platform.
Telehealth-Compatible by Design
SONU operates remotely. Patients scan their face, receive therapy at home, and track outcomes via the app, fitting well with Dentulu’s teledentistry.
Expand Your Scope Without Adding Complexity
Nasal airway management is now part of dental care, especially in sleep dentistry. SONU provides an evidence-based tool for this.
Compatible With
Your Dentulu Workflow
SONU is designed to be recommended, ordered, and monitored within the same teledentistry framework you already use for sleep care on Dentulu. 30-day risk-free trial reduces patient hesitation.
Remote patient onboarding no in-office setup
Multi-profile family sharing (up to 4 per device)
Patient uses smartphone app independently at home
Physician referral code entry for RTM participation
Built-in session tracking and compliance reporting
FSA / HSA eligible — easier patient reimbursement
Inventory Note
Currently limited inventory. Pre-orders shipping late April 2026. Available in Black and Gray. Ships within the United States.
What Medical Experts Are Saying
Leading specialists across ENT, allergy, sleep medicine, and orofacial myofunctional therapy have integrated SONU into their clinical toolkit.
"Vibrational acoustic resonance therapy is safe and effective for the treatment of nasal symptoms associated with allergic and non-allergic rhinitis. SONU is an exciting new treatment option in the ENT toolbox."
Anaïs Rameau, MD
"In my practice, I see many patients with chronic nasal congestion who are looking for non-pharmaceutical options. SONU provides a novel, drug-free approach that has shown promising results in improving nasal airflow and patient quality of life."
Jacob Johnson, MD
"SONU has been a game-changer for my patients with nasal congestion. It's a non-invasive option that has improved their breathing and sleep quality without the need for medications."
Brooklyn SimmonsProvider FAQ
Find answers to common questions about clinical implementation, billing, and regulatory requirements for dental sleep medicine.
Still have questions?
Our team helps you implement Prysm iO from onboarding to integrating scans and protocols into your workflow.
Contact Support @ (888)-905-0226